Imjudo 300mg Injection 15ml

Imjudo 300mg Injection 15ml is an immunotherapy used in the treatment of certain types of cancer. It contains Tremelimumab, a monoclonal antibody and immune checkpoint inhibitor. This medicine is used in combination with other cancer therapies to enhance the body's immune response against cancer cells. It is classified as an anti-cancer drug and is prescribed for conditions including liver cancer and mesothelioma. Imjudo 300mg Injection 15ml must be used with caution. It is not recommended for patients with severe autoimmune diseases or a history of organ transplant, as it may overstimulate the immune system. Imjudo 300mg Injection 15ml should always be administered under the supervision of an oncology specialist. Patients must be regularly monitored during treatment due to potential risks including immune-related reactions affecting the lungs, liver, or endocrine glands. Pregnant or breastfeeding women should avoid this medication unless clearly advised by their doctor.

Imjudo 300mg Injection 15ml is FDA-approved for the treatment of: Unresectable hepatocellular carcinoma (a type of liver cancer), in combination with durvalumab. Malignant pleural mesothelioma (a rare cancer affecting the lining of the lungs), in combination therapies.

This medicine works by helping the body’s immune system recognise and attack cancer cells more effectively. It does this by blocking a protein called CTLA-4 found on certain immune cells. Normally, this protein acts like a brake to prevent the immune system from overreacting. By blocking CTLA-4, Imjudo 300mg Injection 15ml removes this brake, allowing immune cells to stay active longer and fight off cancer cells more powerfully. The result is a more persistent and stronger immune attack on tumours. This approach doesn’t target cancer directly but enhances the body’s natural defences. However, since it amplifies immune activity, it can also cause the immune system to mistakenly attack healthy tissues, which is why medical supervision is essential.

Imjudo 300mg Injection 15ml is given as an intravenous infusion (IV) by a healthcare professional in a clinical setting. The dosage and schedule are decided based on the patient's weight, type of cancer, and overall health. It is not taken with food or at home. It is often given in combination with other medications like durvalumab, usually once every few weeks. Do not attempt to self-administer or alter the treatment schedule without medical guidance.

Common Side Effects: Tiredness or fatigue Diarrhoea or abdominal pain Skin rash or itching Loss of appetite Joint or muscle pain Serious Side Effects: Severe diarrhoea or colitis Breathing difficulty or chest tightness (signs of pneumonitis) Yellowing of the skin or eyes (possible liver issues) Hormonal problems like thyroid imbalance Eye inflammation or vision problems Report any unusual or persistent symptoms to your healthcare provider immediately.

Imjudo 300mg Injection 15ml is a powerful cancer treatment and should only be used under specialist supervision. Patients should attend all scheduled appointments for lab monitoring and report any side effects early. Do not start new medications or supplements without informing your oncologist, as they may interfere with your immune response. Always carry a medical information card that mentions you are receiving immunotherapy. Stay hydrated, eat well, and follow your doctor’s lifestyle advice to support your recovery and treatment outcomes.